Bernard Ross, CEO of Sky Medical Technology, outlines how the NHS can ease pressures in chronic wound care management.
November, December, and January draw huge crowds of pilgrims to south India. Every year, millions travel with devotion and ...
FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Approval from HREC for Phase 1/2 Diabetic Foot Ulcer Trial In ...
INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...
Decision ensures continued patient access to VENDAJE® and VENDAJE AC® POMPANO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused ...
A Class 7 student from a government school in Khammam has developed smart footwear to help diabetic patients prevent foot ...
A Class 7 student from a government school in Khammam has developed smart footwear that uses vibration alerts to improve ...
INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for ...
FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and ...
Three-Way Collaboration to Bring Innovative Oral Mucosal Stem Cell Therapy with U.S. GMP Manufacturing and Commercialization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback